February 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pagaya Technologies Ltd. (“Pagaya” or “the Company”) (NASDAQ: PGY). Investors who purchased Pagaya securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pagaya has violated… read more
February 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmonic Inc. (“Harmonic” or “the Company”) (NASDAQ: HLIT). Investors who purchased Harmonic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmonic has violated federal… read more
February 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS). Investors who purchased GeneDx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GeneDx has violated… read more
February 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eldorado Gold Corporation (“Eldorado” or “the Company”) (NYSE: EGO). Investors who purchased Eldorado securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Eldorado has violated… read more
February 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or “the Company”) (NYSE: HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or “the Company”) (NYSE: HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dominion Energy, Inc. (“Dominion” or “the Company”) (NYSE: D). Investors who purchased Dominion securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dominion has violated… read more
February 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Premier, Inc. (“Premier” or “the Company”) (NASDAQ: PINC). Investors who purchased Premier securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Premier has violated federal… read more
February 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. (“DMC Global” or “the Company”) (NASDAQ: BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Five9, Inc. (“Five9” or “the Company”) (NASDAQ: FIVN). Investors who purchased Five9 securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
February 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. (“Customers Bancorp” or “the Company”) (NYSE: CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ: ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. (“Owens & Minor” or “the Company”) (NYSE: OMI). Investors who purchased Owens & Minor securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
February 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Olin Corporation (“Olin” or “the Company”) (NYSE: OLN). Investors who purchased Olin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Olin has violated federal… read more
January 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. (“Evolv Technologies” or “the Company”) (NASDAQ: EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are encouraged… read more
January 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. (“CARGO” or “the Company”) (NASDAQ: CRGX). Investors who purchased CARGO securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CARGO has violated… read more
January 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged… read more
January 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. (“Flux” or “the Company”) (NASDAQ: FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain… read more
January 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional… read more
January 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA). Investors who purchased Atara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Atara has violated… read more
January 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Midland States Bancorp, Inc. (“Midland States Bancorp” or “the Company”) (NASDAQ: MSBI). Investors who purchased Midland States Bancorp securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
January 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Construction Partners, Inc. (“Construction Partners” or “the Company”) (NASDAQ: ROAD). Investors who purchased Construction Partners securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Construction… read more
January 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ford Motor Company (“Ford” or “the Company”) (NYSE: F). Investors who purchased Ford securities prior to October 28, 2021, and continue to hold to the present, are encouraged to obtain additional… read more
January 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Electronic Arts Inc. (“EA” or “the Company”) (NASDAQ: EA). Investors who purchased EA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether EA has violated… read more
January 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zeta Global Holdings Corp. (“Zeta” or “the Company”) (NYSE: ZETA). Investors who purchased Zeta securities prior to February 27, 2024, and continue to hold to the present, are encouraged to obtain… read more
January 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JinkoSolar Holding Co., Ltd. (“JinkoSolar” or “the Company”) (NYSE: JKS). Investors who purchased JinkoSolar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JinkoSolar has… read more
January 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Keros Therapeutics, Inc. (“Keros” or “the Company”) (NASDAQ: KROS). Investors who purchased Keros securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Keros has violated… read more
January 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sezzle Inc. (“Sezzle” or “the Company”) (NASDAQ: SEZL). Investors who purchased Sezzle securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sezzle has violated federal… read more
January 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XBiotech Inc. (“XBiotech” or “the Company”) (NASDAQ: XBIT). Investors who purchased XBiotech securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether XBiotech has violated federal… read more
January 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. (“Enfusion”) (NYSE: ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation. Investigation Details The investigation concerns whether… read more